NELSON LOUIS LEVY, M.D., PH.D.
Medical Practice at Butler Dr, Green Oaks, IL
License number
Illinois 336.033031
Category
Osteopathic Medicine
Type
Allergy & Immunology
License number
Illinois 336.033031
Category
Osteopathic Medicine
Type
Clinical Pharmacology
License number
Illinois 036-069036
Category
Medical Practice
Type
Neurological Surgery
Address
Address
245 Butler Dr, Green Oaks, IL 60045
Phone
(847) 295-3720
Organization information
See more information about NELSON LOUIS LEVY at bizstanding.comNelson Louis Levy, Ph.D., M.D
245 Butler Dr, Lake Forest, IL 60045
Industry:
Allergist, Neurologist, Neurosurgeon, ...
Registration:
1984
Phone:
(847) 295-3720 (Phone)
Description:
Neurosurgeon. Also Board Certified in Allergy and Immunology. Considerable experience with clinical pharmacology and drug discovery and development.
Nelson Louis Levy
Open Hours:
By Appointment
Licensed:
Yes
Senior discount:
No
Excluded services:
Surgery
Professional information
Dr. Nelson L Levy, Lake Forest IL - MD (Doctor of Medicine)
Specialties:
Neurosurgery, Allergy & Immunology
Address:
245 Butler Dr, Lake Forest 60045
(847) 295-3720 (Phone)
1391 Concord Dr, Lake Forest 60045
(847) 295-3720 (Phone)
(847) 295-3720 (Phone)
1391 Concord Dr, Lake Forest 60045
(847) 295-3720 (Phone)
Certifications:
Allergy & Immunology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia Univ Coll Of Physicians and Surgeons
Graduated: 1967
U Colo Med Ctr
Duke University Hospital
Duke University-Ph.D
Columbia Univ Coll Of Physicians and Surgeons
Graduated: 1967
U Colo Med Ctr
Duke University Hospital
Duke University-Ph.D
Tricyclic Compound Derivatives Useful In The Treatment Of Neoplastic Diseases, Inflammatory Disorders And Immunomodulatory Disorders
US Patent:
2012007, Mar 22, 2012
Filed:
Sep 23, 2011
Appl. No.:
13/242272
Inventors:
Vlad Edward Gregor - Del Mar CA, US
Nelson Levy - Lake Forest IL, US
Nelson Levy - Lake Forest IL, US
International Classification:
A61K 31/4545, A61K 31/5377, A61P 35/00, C12N 9/99, A61P 9/10, A61P 17/06, A61P 37/00, C07D 487/04, A61P 3/10
US Classification:
5142328, 546194, 514318, 546193, 544131, 435184
Abstract:
Provided are compounds of the formula (I):or a stereoisomer, tautomer, salt, hydrate or prodrug thereof that modulate tyrosine kinase activity, compositions comprising the compounds and methods of their use.
Tyrosine Kinase Inhibitors
US Patent:
2012006, Mar 15, 2012
Filed:
Sep 13, 2011
Appl. No.:
13/231797
Inventors:
Vlad Edward GREGOR - Del Mar CA, US
Nelson Levy - Lake Forest IL, US
Nelson Levy - Lake Forest IL, US
International Classification:
A61K 31/4439, A61P 35/00, C12N 9/99, C07D 487/04
US Classification:
514338, 5462731, 435184
Abstract:
The present disclosure relates to the field of tyrosine kinase enzyme inhibition, in particular anaplastic lymphoma kinase (ALK) inhibition using novel small molecules. Provided are compounds capable to modulate ALK activity, compositions that comprise the compounds, and methods of using the compounds for the treatment or prevention of diseases or conditions that are characterized by ALK activity or expression.